Exane Derivatives’s Citigroup C Stock Holding History

Exane Derivatives’s Portfolio C Stock Details C Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.32M	Buy	50,565 +10,292	+26%	+$515K	1.34%	12
2022 Q1	$2.15M	Sell	40,273 -3,459	-8%	-$214K	0.61%	30
2021 Q4	$2.64M	Buy	43,732 +8,405	+24%	+$559K	0.64%	26
2021 Q3	$2.48M	Buy	35,327 +2,151	+6%	+$150K	0.6%	29
2021 Q2	$2.27M	Buy	+33,176	New	+$2.45M	0.51%	32
2020 Q4	–	Sell	-1,681	Closed	-$72.5K	–	837
2020 Q3	$72.5K	Sell	1,681 -15,624	-90%	-$778K	0.02%	342
2020 Q2	$884K	Buy	17,305 +4,438	+34%	+$211K	0.24%	92
2020 Q1	$542K	Buy	12,867 +6,888	+115%	+$462K	0.15%	116
2019 Q4	$486K	Sell	5,979 -339	-5%	-$25K	0.09%	169
2019 Q3	$436K	Hold	6,318	–	–	0.08%	170
2019 Q2	$442K	Sell	6,318 -2,035	-24%	-$136K	0.08%	182
2019 Q1	$520K	Sell	8,353 -1,348	-14%	-$83.7K	0.1%	150
2018 Q4	$505K	Buy	9,701 +1,900	+24%	+$120K	0.09%	173
2018 Q3	$562K	Buy	7,801 +6,938	+804%	+$491K	0.11%	152
2018 Q2	$59.1K	Buy	863 +221	+34%	+$15.2K	0.01%	377
2018 Q1	$43.8K	Buy	642 +464	+261%	+$34.9K	0.01%	359
2017 Q4	$13.3K	Sell	178 -2,174	-92%	-$161K	﹤0.01%	389
2017 Q3	$171K	Sell	2,352 -2,699	-53%	-$184K	0.03%	206
2017 Q2	$338K	Buy	5,051 +447	+10%	+$27.4K	0.07%	164
2017 Q1	$275K	Buy	+4,604	New	+$272K	0.06%	172
2016 Q4	–	Sell	-18,579	Closed	-$1M	–	652
2016 Q3	$877K	Sell	18,579 -10,352	-36%	-$471K	0.13%	99
2016 Q2	$1.23M	Sell	28,931 -5,753	-17%	-$254K	0.2%	77
2016 Q1	$1.45M	Buy	34,684 +8,870	+34%	+$371K	0.19%	70
2015 Q4	$1.34M	Buy	25,814 +7,855	+44%	+$417K	0.18%	72
2015 Q3	$891K	Sell	17,959 -21,925	-55%	-$1.2M	0.11%	95
2015 Q2	$2.2M	Buy	39,884 +6,249	+19%	+$340K	0.24%	62
2015 Q1	$1.73M	Sell	33,635 -76,239	-69%	-$3.88M	0.19%	70
2014 Q4	$5.94M	Buy	+109,874	New	+$5.83M	0.82%	40

Other funds holding C

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Exane Derivatives's C Position: Q2 2022 in Review

Exane Derivatives increased its Citigroup (C) stake by 26% in Q2 2022, buying an estimated $515K and bringing the position to 50,565 shares worth $2.32M. The position accounts for 1.34% of the portfolio, ranked #12.

Exane Derivatives first reported a position in C in Q4 2014 and has held it in 28 quarters since. The position peaked at $5.94M in Q4 2014. 1,660 funds tracked by Wall St. Rank hold C as of Q2 2022.

Exane Derivatives held 50,565 shares of Citigroup worth $2.32M as of Q2 2022.
Exane Derivatives bought 10,292 Citigroup shares in Q2 2022, an estimated $515K.
Citigroup made up 1.34% of Exane Derivatives's portfolio in Q2 2022, its #12 holding.
Exane Derivatives first reported a position in Citigroup in Q4 2014 and has held it in 28 quarters since.
Exane Derivatives's Citigroup position peaked at $5.94M in Q4 2014.
1,660 funds tracked by Wall St. Rank held Citigroup as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.